Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Impact of Smoking Information on Concerns About Radon

17 avril 2019 mis à jour par: Paul Windschitl
Despite a push for tailored messages, health communications are often aimed at, and viewed by, people with varying levels of risk. This project examined-in the context of radon risk messages-whether information relevant to high-risk individuals can have an unintended influence on lower-risk individuals. Specifically, the investigators assessed whether information about lung-cancer risk from smoking reduced concerns about lung-cancer risk from radon among nonsmokers. The investigators hypothesized that non-smokers who read a message that included smoking-relevant information would express less concern about the effects of radon exposure and less interest in testing their home compared to those who read a version in which smoking-relevant information was excluded. Two studies were conducted. Although the investigators did not exclude smokers, the focus was on participants self-identifying as nonsmokers (including never smokers and former smokers).

Aperçu de l'étude

Description détaillée

Despite a push for tailored messages, health communications are often aimed at, and viewed by, people with varying levels of risk. This project examined-in the context of radon risk messages-whether information relevant to high-risk individuals can have an unintended influence on lower-risk individuals. Specifically, the investigators assessed whether information about lung-cancer risk from smoking reduced concerns about lung-cancer risk from radon among nonsmokers. The investigators hypothesized that non-smokers who read a message that included smoking-relevant information would express less concern about the effects of radon exposure and less interest in testing their home compared to those who read a version in which smoking-relevant information was excluded. Two studies were conducted. Although the investigators did not exclude smokers, the focus was on participants self-identifying as nonsmokers (including never smokers and former smokers). Participants in both studies were recruited through Amazon's Mechanical Turk (MTurk). Participants viewed radon messages that varied in the information they communicated about smoking's effect on lung cancer. In Study 1, smoking information was included or excluded from messages assembled from existing radon pamphlets. In Study 2, versions of a new radon message either excluded smoking information, described smoking as a major cause of lung cancer, or also described smoking's synergistic effect with radon on lung cancer risk. After viewing a radon health message, participants completed a variety of measures. Primary measures assessed respondents' anticipated sense of concern and related reactions if they learned that they/their home had been exposed to elevated levels of radon. Other key measures included questions about participants' interest and intention to test their home for radon.

Type d'étude

Interventionnel

Inscription (Réel)

1390

Phase

  • N'est pas applicable

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans et plus (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Live within the US
  • Have an Amazon Mechanical Turk account (website where online study was posted)

Exclusion Criteria:

  • None

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: La prévention
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation factorielle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Comparateur actif: Study 1: Radon&Smoking Synergistic/EPA
Participants viewed radon and smoking risk information taken from the EPA's pamphlet on the dangers of radon gas exposure.
Participants viewed health information detailing the risks of developing lung cancer from exposure to radon gas, smoking, and their synergistic effects. This intervention represents the type of information most commonly presented in radon risk communications.
Health information modeled after the Environmental Protection Agency's (EPA) pamphlet on radon risk.
Comparateur actif: Study 1: Radon&Smoking Synergistic/Idaho
Participants viewed radon and smoking risk information taken from Idaho's Department of Health and Human Welfare's pamphlet on the dangers of radon gas exposure.
Participants viewed health information detailing the risks of developing lung cancer from exposure to radon gas, smoking, and their synergistic effects. This intervention represents the type of information most commonly presented in radon risk communications.
Health information modeled after the Idaho Department of Health and Human Welfare's pamphlet on radon risk.
Expérimental: Study 1: Radon Only / EPA
Participants viewed only radon risk information taken from the EPA's pamphlet on the dangers of radon gas exposure.
Health information modeled after the Environmental Protection Agency's (EPA) pamphlet on radon risk.
Participants viewed health information detailing the risks of developing lung cancer from radon exposure. No information about the risks for developing lung cancer associated with smoking or its synergistic effect with radon exposure are included.
Expérimental: Study 1: Radon Only / Idaho
Participants viewed only radon risk information taken from Idaho's Department of Health and Human Welfare's pamphlet on the dangers of radon gas exposure.
Health information modeled after the Idaho Department of Health and Human Welfare's pamphlet on radon risk.
Participants viewed health information detailing the risks of developing lung cancer from radon exposure. No information about the risks for developing lung cancer associated with smoking or its synergistic effect with radon exposure are included.
Expérimental: Study 2: Radon Only
Participants viewed a radon-only message that focused only on the effect of radon on lung-cancer risk.
Participants viewed health information detailing the risks of developing lung cancer from radon exposure. No information about the risks for developing lung cancer associated with smoking or its synergistic effect with radon exposure are included.
Autre: Study 2: Radon and Smoking Isolated
Participants viewed a radon-and-smoking-isolated message that covered the individual effects of radon and of smoking on lung cancer, but without mentioning their synergistic effect.
Participants viewed health information detailing the risks of developing lung cancer from radon exposure and smoking. No information describing the synergistic effects of smoking and radon exposure on lung cancer risk are included.
Comparateur actif: Study 2: Radon & Smoking Synergistic
Participants viewed a radon-and-smoking-synergistic message that covered the individual effects of radon and of smoking but that also included information about their synergistic effect.
Participants viewed health information detailing the risks of developing lung cancer from exposure to radon gas, smoking, and their synergistic effects. This intervention represents the type of information most commonly presented in radon risk communications.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Conditional Concern Composite
Délai: Immediately post-intervention (approx. 1 minute)
Composite formed from 4 conditional questions assessing concern, perceived impact on risk and comparative risk, and threat--if exposed to radon
Immediately post-intervention (approx. 1 minute)
Interest in Testing Composite
Délai: Immediately post-intervention (approx. 2 minutes)
Composite formed from 2 questions assessing importance and intention to test home for radon
Immediately post-intervention (approx. 2 minutes)

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Worry Elicited by Health Message
Délai: Immediately post-intervention (approx. 2 minutes)
Single question assessing worry elicited by the health communication material
Immediately post-intervention (approx. 2 minutes)
Likelihood Judgments about Lung Cancer
Délai: Immediately post-intervention (approx. 4 minutes)
Three items assessing perceived likelihood of developing lung cancer
Immediately post-intervention (approx. 4 minutes)
Elect to Leave Email for Raffle
Délai: Immediately post-intervention (approx. 4 minutes)
Participants given option to leave email address in case they won one of the 20 radon kits being raffled (Study 2).
Immediately post-intervention (approx. 4 minutes)
Elect to Read More
Délai: Immediately post-intervention (approx. 4 minutes)
Participants given option to be presented with more information at the end of the session about testing for radon (Study 2).
Immediately post-intervention (approx. 4 minutes)
Concern about Loved Ones If Exposed to Radon
Délai: Immediately post-intervention (approx. 4 minutes)
Rated how concerned they would be about loved ones if they learned their home had high radon (Study 2)
Immediately post-intervention (approx. 4 minutes)

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

7 août 2015

Achèvement primaire (Réel)

22 avril 2016

Achèvement de l'étude (Réel)

22 avril 2016

Dates d'inscription aux études

Première soumission

30 mars 2018

Première soumission répondant aux critères de contrôle qualité

13 avril 2018

Première publication (Réel)

17 avril 2018

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

19 avril 2019

Dernière mise à jour soumise répondant aux critères de contrôle qualité

17 avril 2019

Dernière vérification

1 avril 2019

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • 201507727

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

OUI

Description du régime IPD

De-identified data and guide will be made available to other investigators upon request.

Délai de partage IPD

Requested data will be made available upon publication of the project.

Critères d'accès au partage IPD

Please contact corresponding author Dr. Paul Windschitl at paul-windschitl@uiowa.edu

Type d'informations de prise en charge du partage d'IPD

  • ANALYTIC_CODE

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

Essais cliniques sur Radon & Smoking Synergistic

S'abonner